ut-logo website  
Register and login to access premium content
Log in
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.

Log in

 

Prostate Cancer

Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer - Abstract

PURPOSE: To explore differential methylation of HAAO, HOXD3, LGALS3, PITX2, RASSF1 and TDRD1 as a molecular tool to predict biochemical recurrence (BCR) in patients with high-risk prostate cancer (PCa).

Read more...

MED12 overexpression is a frequent event in castration-resistant prostate cancer - Abstract

In a recent effort to unravel the molecular basis of prostate cancer (PCa), Barbieri and colleagues using whole-exome sequencing identified a novel recurrently mutated gene, MED12, in 5.4% of primary PCa.

Read more...

Best practices recommendations in the application of immunohistochemistry in the prostate: Report from the International Society of Urologic Pathology Consensus Conference - Abstract

The following are the International Society of Urological Pathology (ISUP) recommendations for the use of immunohistochemistry (IHC) in prostate specimens.

Read more...

Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: Results from a prospective study - Abstract

Purpose: To evaluate outcomes of patients with high risk prostate cancer (PCa) who underwent radical prostatectomy (RP) in a context of a multidisciplinary approach including adjuvant radiation (RT) + androgen deprivation therapy (ADT).

Read more...

Adherence to dietary and lifestyle recommendations and prostate cancer risk in the Prostate Testing for Cancer and Treatment (ProtecT) trial - Abstract

Background: The World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) published eight recommendations for cancer prevention but they are not targeted at prostate cancer prevention.

Read more...

Evaluation of various active surveillance protocols in prostate cancer - Abstract

Objective: This study aims to investigate whether pathology results obtained by radical retropubic prostatectomy (RRP) were correlated with active surveillance (AS) criteria defined by Klotz, Soloway and D'Amico.

Read more...

Population-based assessment of prostate-specific antigen testing for prostate cancer in the elderly - Abstract

OBJECTIVES: To perform a population-based analysis to characterize the effect of prostate-specific antigen (PSA) testing on oncologic outcomes in men diagnosed with prostate cancer.

Read more...

Counseling men with post-prostatectomy SUI to assist them in setting realistic expectations prior to transobturator sling placement, "Beyond the Abstract," by Michael L. Guralnick, MD, FRCSC and R. Corey O’Connor, MD, FACS

BERKELEY, CA (UroToday.com) - Stress urinary incontinence (SUI) after radical prostatectomy can be a devastating outcome for a patient despite the successful eradication of cancer.

Read more...

Influence of hormonal therapy in prostate cancer patients undergoing 18Fluoromethylcholine PET/CT: A retrospective study - Abstract

AIM: Patients with suspected recurrence of prostate cancer undergoing 18Fluoromethylcholine (18FCH) PET/CT were retrospectively evaluated to investigate the influence of hormonal therapy (HT) in 18FCH uptake.

Read more...

High-dose-rate brachytherapy with two or three fractions as monotherapy in the treatment of locally advanced prostate cancer - Abstract

BACKGROUND: To evaluate late urinary (GU) and gastrointestinal (GI) adverse events (AEs) and biochemical control of disease after high-dose rate brachytherapy (HDR-BT) in locally advanced prostate cancer.

Read more...

Page 1 of 987